Abrysvo Injection, Powder, Lyophilized, For Solution
Product Images NDC 0069-2465

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Abrysvo (NDC 0069-2465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial (Abrysvo 01)

FDA Label Image

Syringe (Abrysvo 02)

Syringe (Abrysvo 02)
The text appears to be a description of a syringe cap with a Luer lock adapter. It is used as an accessory for securing syringes and ensuring a secure connection between the syringe and other medical devices or needles. The Luer lock adapter helps prevent accidental disconnection during medical procedures.*
FDA Label Image

Vial Adapter (Abrysvo 03)

FDA Label Image

Step 1 (Abrysvo 04)

FDA Label Image

Step 2 (Abrysvo 05)

FDA Label Image

Step 3 (Abrysvo 06)

FDA Label Image

Step 4 (Abrysvo 07)

FDA Label Image

Step 5 (Abrysvo 08)

FDA Label Image

Step 6 (Abrysvo 09)

FDA Label Image

Step 7 (Abrysvo 10)

FDA Label Image

Step 8 (Abrysvo 11)

FDA Label Image

Step 9 (Abrysvo 12)

FDA Label Image

Logo (Abrysvo 13)

FDA Label Image

Principal Display Panel (10 Vial/Syringe Kit Carton)

FDA Label Image

Principal Display Panel (5 Vial/Syringe Kit Carton)

FDA Label Image

Principal Display Panel (1 Vial/Syringe Kit Carton)

FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Principal Display Panel (0.5 mL Vial Label)
This text appears to be a description of a pharmaceutical product. The product is identified by the code "PAA209777" and the National Drug Code (NDC) "0069-0207-01". It is a lyophilized antigen component intended for use as part of a respiratory syncytial virus vaccine called ABRYSVO™. The text instructs users not to use the antigen component alone and to reconstitute it with sterile water diluent. The vaccine is manufactured by Pfizer Inc. and is provided in a single dose of approximately 0.5 mL after reconstitution. The code at the end, "01)10300690207015", seems to be some form of identification or batch number.*
FDA Label Image

Principal Display Panel (1 Syringe Label)

Principal Display Panel (1 Syringe Label)
This is a description of a component called "Sterile Water Diluent" used in the production of a respiratory syncytial virus vaccine called ABRYSVO™. It is not to be used alone, but rather added to another vial of lyophilized antigen component to form the vaccine. The product is manufactured by Pfizer Inc., holds a U.S. license number 2001, and is for prescription use only. Unfortunately, the text does not provide any information about the lot number or expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.